News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99,844 Results
Type
Article (4354)
Company Profile (265)
Press Release (95225)
Multimedia
Podcasts (11)
Webinars (1)
Section
Business (38722)
Career Advice (135)
Deals (6025)
Drug Delivery (13)
Drug Development (12119)
Employer Resources (17)
FDA (2209)
Job Trends (2444)
News (53966)
Policy (3888)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (8)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (266)
Accelerated approval (14)
ADA (9)
Adcomms (4)
Allergies (41)
Alliances (3873)
ALS (29)
Alzheimer's disease (278)
Antibody-drug conjugate (ADC) (138)
Approvals (2366)
Artificial intelligence (72)
ASCO (75)
Autoimmune disease (75)
Automation (3)
Bankruptcy (28)
Belgium (1)
Best Places to Work (2259)
BIO (37)
Biologics (1)
BIOSECURE Act (1)
Biosimilars (39)
BioSpace Insights (7)
Biotechnology (175)
Bladder cancer (65)
Brain cancer (13)
Breast cancer (188)
Cancer (1465)
Cardiovascular disease (94)
Career advice (114)
Career pathing (3)
CAR-T (69)
CDC (4)
CDMO (14)
Celiac Disease (1)
Cell therapy (149)
Cervical cancer (14)
Clinical research (11800)
Collaboration (206)
Company closure (1)
Compensation (151)
Complete response letters (17)
COVID-19 (352)
CRISPR (12)
C-suite (101)
Cystic fibrosis (16)
Data (2179)
Decentralized trials (1)
Denatured (1)
Depression (35)
Dermatology (30)
Diabetes (139)
Diagnostics (1049)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (39)
Drug pricing (27)
Drug shortages (2)
Duchenne muscular dystrophy (63)
Earnings (30566)
Editorial (14)
Employer branding (3)
Employer resources (15)
Events (15053)
Executive appointments (81)
FDA (3102)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (208)
Gene editing (31)
Generative AI (6)
Gene therapy (106)
GLP-1 (252)
Government (604)
Grass and pollen (1)
Guidances (269)
Healthcare (2969)
Hematology (45)
HIV (16)
Huntington's disease (6)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (13)
Immunology and inflammation (55)
Immuno-oncology (21)
Indications (57)
Infectious disease (417)
Inflammatory bowel disease (36)
Inflation Reduction Act (2)
Influenza (22)
Intellectual property (36)
Interviews (20)
IPO (4136)
IRA (7)
Job creations (371)
Job search strategy (104)
JPM (8)
Kidney cancer (5)
Labor market (26)
Layoffs (100)
Leadership (4)
Legal (706)
Licensing (2)
Liver cancer (18)
Longevity (2)
Lung cancer (227)
Lymphoma (163)
Machine learning (9)
Management (4)
Manufacturing (120)
Marketing (3)
MASH (59)
Medical device (2317)
Medtech (2354)
Mergers & acquisitions (2107)
Metabolic disorders (375)
mRNA (40)
Multiple sclerosis (36)
NASH (4)
Netherlands (1)
Neurodegenerative disease (72)
Neuropsychiatric disorders (24)
Neuroscience (551)
NextGen: Class of 2026 (890)
Non-profit (558)
Now hiring (7)
Obesity (172)
Opinion (24)
Ovarian cancer (46)
Pain (26)
Pancreatic cancer (68)
Parkinson's disease (55)
Partnered (1)
Patents (55)
Patient recruitment (103)
Peanut (21)
People (3986)
Pharmaceutical (53)
Pharmacy benefit managers (4)
Phase 1 (2872)
Phase 2 (4944)
Phase 3 (4880)
Pipeline (3373)
Policy (35)
Postmarket research (444)
Preclinical (992)
Press Release (8)
Prostate cancer (73)
Psychedelics (7)
Radiopharmaceuticals (59)
Rare diseases (208)
Real estate (491)
Recruiting (10)
Regulatory (3566)
Reports (15)
Research institute (241)
Resumes & cover letters (12)
Rett syndrome (16)
RNA editing (3)
RSV (23)
Schizophrenia (37)
Series A (29)
Series B (28)
Service/supplier (9)
Sickle cell disease (28)
Special edition (3)
Spinal muscular atrophy (29)
Sponsored (6)
Startups (309)
Stomach cancer (3)
Supply chain (12)
Tariffs (9)
The Weekly (9)
Vaccines (153)
Venture capital (16)
Weight loss (126)
Women's health (24)
Worklife (2)
Date
Today (22)
Last 7 days (79)
Last 30 days (414)
Last 365 days (5834)
2026 (4053)
2025 (5654)
2024 (6756)
2023 (6934)
2022 (8387)
2021 (8864)
2020 (8083)
2019 (6748)
2018 (4749)
2017 (4275)
2016 (3591)
2015 (4273)
2014 (3197)
2013 (2484)
2012 (2533)
2011 (3076)
2010 (3022)
Location
Africa (82)
Alabama (11)
Alaska (2)
Arizona (44)
Arkansas (3)
Asia (6228)
Australia (811)
California (2773)
Canada (818)
China (298)
Colorado (147)
Connecticut (126)
Delaware (142)
Europe (15593)
Florida (363)
Georgia (86)
Hawaii (2)
Idaho (7)
Illinois (241)
India (21)
Indiana (190)
Iowa (2)
Japan (146)
Kansas (20)
Kentucky (10)
Louisiana (13)
Maine (28)
Maryland (330)
Massachusetts (1840)
Michigan (69)
Minnesota (150)
Mississippi (1)
Missouri (23)
Montana (6)
Nebraska (1)
Nevada (23)
New Hampshire (17)
New Jersey (1029)
New Mexico (2)
New York (691)
North Carolina (336)
Northern California (1455)
Ohio (59)
Oklahoma (2)
Oregon (5)
Pennsylvania (620)
Puerto Rico (4)
Rhode Island (4)
South America (141)
South Carolina (9)
Southern California (1026)
Tennessee (31)
Texas (394)
United States (9841)
Utah (85)
Virginia (53)
Washington D.C. (13)
Washington State (230)
Wisconsin (25)
99,844 Results for "22".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novo Nordisk A/S - share repurchase programme - June 22, 2026
June 22, 2026
·
2 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
September 8, 2026
·
11 min read
Press Releases
Telix to Host R&D Day in New York City on September 22, 2026
August 5, 2026
·
6 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
Registration Link for Phio’s Presentation on Thursday, January 22 at 1:45 PM ET
January 15, 2026
·
5 min read
Press Releases
Medicus Pharma Announces $22 Million Non-Dilutive Financing
May 28, 2026
·
9 min read
Press Releases
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 22, 2026
July 23, 2026
·
1 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
June 5, 2026
·
4 min read
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - June 22, 2026
June 22, 2026
·
2 min read
Press Releases
Ampersand Biomedicines Presents Preclinical Data on AMP-220, a Gut-Targeted IL-22 AND-Body™ Therapeutic, at AAI 2026
April 20, 2026
·
3 min read
1 of 9,985
Next
